Home › Funds › Patient Capital Management, LLC › NVDA

Patient Capital Management, LLC position in NVDA

NVIDIA CORPORATION · Technology

Patient Capital Management, LLC reported holding 709,927 shares of NVDA (NVIDIA CORPORATION) in its Q3 2026 13F filing — a position valued at US$162.1M, representing 5.48% of its reported portfolio and ranking #5 among its reported holdings. Patient Capital Management, LLC has disclosed NVDA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)709.93K sh
Reported value held$162.13M
Portfolio Weight5.48%
First reportedQ1 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's NVDA position evolved

Patient Capital Management, LLC first disclosed a stake in NVDA in Q1 2024 at 60,606 shares (US$54.8M). The position peaked in Q3 2026 at 709,927 shares, worth US$162.1M. Across 11 filings, Patient Capital Management, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 709,927 shares valued at US$162.1M. Notable position changes include a 900% increase in Q2 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 60.61K $54.76M New
Q2 2024 605.84K $74.85M Add
Q3 2024 608.73K $73.92M Hold
Q4 2024 608.56K $81.72M Hold
Q1 2025 626.95K $67.95M Add
Q2 2025 634.17K $100.19M Add
Q3 2025 632.68K $118.05M Hold
Q4 2025 638.81K $119.14M Add
Q1 2026 711.12K $124.02M Add
Q2 2026 709.59K $141.98M Hold
Q3 2026 709.93K $162.13M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVDA and 13F data

NVDA (NVIDIA CORPORATION) is a Technology company. 45 other funds we track also report a position in NVDA — the largest reported positions include Vanguard Group (US$422.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$351.84B), STATE STREET CORP (US$234.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVDA

All NVDA fund holders →

FAQ

How long has Patient Capital Management, LLC held NVDA?

Patient Capital Management, LLC has disclosed NVDA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Patient Capital Management, LLC's current position in NVDA?

As of Q3 2026, Patient Capital Management, LLC holds 709.93K shares of NVDA (NVIDIA CORPORATION), valued at $162.13M, representing 5.48% of its reported portfolio and ranking #5.

Has Patient Capital Management, LLC been buying or selling NVDA?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC held unchanged its position in NVDA. The position peaked in Q3 2026 at 709.93K shares.

Which other funds hold NVDA?

Other major institutional holders of NVDA include Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.